These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39044836)

  • 1. Older age is associated with a distinct and marked reduction of functionality of both alloreactive CD4+ and CD8+ T cells.
    Litjens NHR; van der List ACJ; Klepper M; Reijerkerk D; Prevoo F; Betjes MGH
    Front Immunol; 2024; 15():1406716. PubMed ID: 39044836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Loss of Donor-Reactive CD4
    van der List ACJ; Litjens NHR; Klepper M; Prevoo F; Betjes MGH
    J Immunol; 2022 Oct; 209(7):1389-1400. PubMed ID: 36165198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation.
    Fischer M; Leyking S; Schäfer M; Elsäßer J; Janssen M; Mihm J; van Bentum K; Fliser D; Sester M; Sester U
    Eur J Immunol; 2017 Jul; 47(7):1220-1231. PubMed ID: 28426152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopeptide-specific CD4(+) T cells facilitate the differentiation of directly alloreactive graft-infiltrating CD8(+) T Cells.
    Richards DM; Zhang N; Dalheimer SL; Mueller DL
    Am J Transplant; 2007 Oct; 7(10):2269-78. PubMed ID: 17845562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year.
    Taner T; Gustafson MP; Hansen MJ; Park WD; Bornschlegl S; Dietz AB; Stegall MD
    Kidney Int; 2018 Jun; 93(6):1465-1474. PubMed ID: 29656904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactive memory CD4 T cells promote transplant rejection by engaging DCs to induce innate inflammation and CD8 T cell priming.
    Saha I; Chawla AS; Oliveira APBN; Elfers EE; Warrick K; Meibers HE; Jain VG; Hagan T; Katz JD; Pasare C
    Proc Natl Acad Sci U S A; 2024 Aug; 121(34):e2401658121. PubMed ID: 39136987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Senescence Marker TIGIT Identifies Polyfunctional Donor-Reactive CD4+ T Cells Preferentially Lost After Kidney Transplantation.
    van der List ACJ; Litjens NHR; Klepper M; Betjes MGH
    Front Immunol; 2021; 12():656846. PubMed ID: 33995373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactive T Cells to Identify Risk HLA Alleles for Retransplantation After Acute Accelerated Steroid-Resistant Rejection.
    Leyking S; Wolf M; Mihm J; Schaefer M; Bohle RM; Fliser D; Sester M; Sester U
    Transplant Proc; 2015 Oct; 47(8):2425-32. PubMed ID: 26518945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced CD137 is a fast assay for identification and multi-parameter flow cytometric analysis of alloreactive T cells.
    Litjens NH; de Wit EA; Baan CC; Betjes MG
    Clin Exp Immunol; 2013 Oct; 174(1):179-91. PubMed ID: 23750604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of alloreactive T cells measured before renal transplantation.
    van de Berg PJ; Yong SL; Koch SD; Lardy N; van Donselaar-van der Pant KA; Florquin S; Bemelman FJ; van Lier RA; ten Berge IJ
    Clin Exp Immunol; 2012 May; 168(2):241-50. PubMed ID: 22471286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
    Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
    Front Immunol; 2020; 11():623276. PubMed ID: 33776988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged graft survival in older recipient mice is determined by impaired effector T-cell but intact regulatory T-cell responses.
    Denecke C; Bedi DS; Ge X; Kim IK; Jurisch A; Weiland A; Habicht A; Li XC; Tullius SG
    PLoS One; 2010 Feb; 5(2):e9232. PubMed ID: 20169060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection.
    Steger U; Denecke C; Sawitzki B; Karim M; Jones ND; Wood KJ
    Transplantation; 2008 May; 85(9):1339-47. PubMed ID: 18475193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
    Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW
    J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-resident memory T cells in human kidney transplants have alloreactive potential.
    Hullegie-Peelen DM; Tejeda-Mora H; Dieterich M; Heidt S; Bindels EMJ; Hoogduijn MJ; Hesselink DA; Baan CC
    Am J Transplant; 2024 Aug; 24(8):1406-1413. PubMed ID: 38447886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory phenotype and polyfunctional T cells in kidney transplant patients.
    Ortiz YM; Arias LF; Alvarez CM; García LF
    Transpl Immunol; 2013 Mar; 28(2-3):127-37. PubMed ID: 23499948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.
    Betjes MGH; Litjens NHR
    PLoS One; 2020; 15(2):e0228096. PubMed ID: 32023273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.